GetPortalImpactFactorByIdResp(projectId=1, id=4deb2390, cover=https://img.medsci.cn/images/journal/cover/2021/esf_202109271315018010.jpg, fullname=EXPERT OPINION ON THERAPEUTIC TARGETS, abbr=EXPERT OPIN THER TAR, pyear=2001, frequence=Monthly, articleNumbers=1144, citedSelf2015=0.8, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均4月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1472-8222, greenSci=https://www.greensci.net/search?kw=1472-8222, scijournal=https://www.scijournal.org/impact-factor-of-EXPERT-OPIN-THER-TAR.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.428, medsciHotlight=3.137, medsciHotlight5year=3.93629, citescore=9.0, hIndex=89, impactFactor=5.8, orgnization=Taylor and Francis Ltd., orgnizationUrl=http://www.informapharmascienc, country=United Kingdom, countryCn=英国, isOa=3, isOaString=部分OA, sciScie=Science Citation Index Expanded|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.tandfonline.com/loi/iett20#.V48c20z9cSQ, websiteHits=8162, guideForAuthor=null, guideForAuthorHits=1, submitWebsite=https://mc.manuscriptcentral.com/eott, submitWebsiteHits=2140, content=Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1472-8222.<br /><br />Expert Opinion on Therapeutic Targets is the premier journal dedicated to in-depth reports and reviews of the latest developments in the field of drug target discovery and validation. Expert Opinion on Therapeutic Targets is a peer-reviewed journal providing evaluated and expert reviews of recent research identifying novel molecular drug targets. The journal provides an essential link between basic research on biological pathways and interactions, and the development of the drugs of tomorrow. It is distinguished from other publications by its high-quality authorship and expertly drafted articles which are structured to incorporate the author's own expertise on the subject. The audience consists of scientists, managers and decision makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, as well as many biotechnology companies., totalCites=6639, brief=EXPERT OPIN THER TAR杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的中等级别杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=EXPERT OPIN THER TAR在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=4deb2390'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=5444, tagName=药物靶点, createdHits=1), ImpactFactorTagDto(id=469187, tagName=靶向纳米制剂, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=4.26), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.18), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.13), GetImpactFactorCiteScoreListResponse(year=2019, citescore=8.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=9.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.749), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.932), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.782), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.93), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.428)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Clinical Biochemistry , rank=10/115), GetImpactFactorCiteScoreGradeResponse(smallClass=Drug Discovery , rank=11/143), GetImpactFactorCiteScoreGradeResponse(smallClass=Molecular Medicine , rank=21/165), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology , rank=22/301)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY - SCIE , rank=21/270)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-8222[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Expert Opinion on Therapeutic Targets[ta], article_number=80, article_number_cn=7, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)